openPR Logo
Press release

Real-World Evidence (RWE) Solutions Market will reach $1.64 billion by 2024, Anthem, Inc., Clinigen Group, Cognizant, IBM, ICON plc, IQVIA, Optum, Oracle, PAREXEL, PerkinElmer, Inc., PPD, SAS, and Syneos Health.

03-01-2019 11:31 AM CET | IT, New Media & Software

Press release from: Meticulous search®

Real-World Evidence (RWE) Solutions Market will reach $1.64

A report into the projected growth of the current Real-World Evidence (RWE) solutions market by Meticulous Research® has produced lucrative forecasts for the industry. By 2024, it’s expected to have grown at a compound annual growth rate (CAGR) of 15.0%, reaching $1.64 billion.

Download free sample @ https://www.meticulousresearch.com/download-sample-report/cp_id=4954

The researchers suggest that the growth of Real-World Evidence (RWE) solutions market will be driven by factors including the rising geriatric population and burden of chronic diseases, shift towards value-based care, increasing R&D expenditure by the life sciences industry, delays in drug development and the subsequent increase in development costs, and expanding use of RWE for regulatory decision making.

The report states that data sets currently account for the largest share of the total market and is expected to grow at a CAGR of 13.8% from 2019 to 2024. Meticulous Research® identified as to why this segment will continue dominating over real-world evidence services: “Due to increasing need for additional insights on epidemiology, compliance, adherence and costs in a realistic environment; growing amount of medical data generated in hospitals; increasing dependence of outcome-based studies on real-world data; and rising demand for information by the payers, regulatory bodies and providers regarding drug safety.”

Based on application, drug development and approvals commanded the largest share in 2018 owing to significant demand of RWD and RWE to accelerate drug discovery and development, increasing investment by biopharmaceutical companies in R&D, and growing inclination of regulatory bodies towards RWE.

Pharmaceutical, biotechnology & medical device companies were the leading adopters of real-world evidence solutions in 2018 and are also expected to register fastest growth during the forecast period. This is attributed to the increasing importance of RWE studies in drug development and approvals, growing focus to avoid costly drug recalls, increasing need to assess drug performance in real-world settings, and growing emphasis on drug safety and post-market surveillance.

Real World Evidence (RWE) Solutions Market by Component (RWD, EMR, Claim, Patient Registry, Pharmacy, Service), Application (Oncology, CVD, Neuro, Infection, Regulatory), End User (Pharma, Biotech, Medical Devices, Payers, Healthcare) - Global Forecast to 2024

Browse in-depth Report on: https://www.meticulousresearch.com/product/real-world-evidence-solutions-market/253/

North America is currently home for most of the real-world evidence solutions providers and is the leading adopter of RWD and RWE. The largest as well as fastest growth of this region is supported by significant availability of real-world data sets, growing focus on value-based care, rising R&D expenditure by the biopharma companies, greater emphasis on early drug/device development and approvals, stringent regulations for drug approvals, and favorable government policies (implementation of 21st Century Cures Act (December 2016) and FDA’s new 2019 strategic Framework for RWE (December 2018) in the U.S).

The key players operating in the global real-world evidence (REW) solutions market are
Anthem, Inc.
Clinigen Group
Cognizant
IBM
ICON
IQVIA
Optum,Inc.
Oracle
PAREXEL
PerkinElmer
PPD
SAS and
Syneos Health

Download free sample @ https://www.meticulousresearch.com/download-sample-report/cp_id=4954

About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

Contact us :
Khushal
Email: khushal@meticulousresearch.com
Contact: +1-646-781-8004
Office No-202, 2nd Floor, Pushpak Business Hub, Wakad, Pune-411057

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Real-World Evidence (RWE) Solutions Market will reach $1.64 billion by 2024, Anthem, Inc., Clinigen Group, Cognizant, IBM, ICON plc, IQVIA, Optum, Oracle, PAREXEL, PerkinElmer, Inc., PPD, SAS, and Syneos Health. here

News-ID: 1626267 • Views:

More Releases from Meticulous search®

Pea Protein Market Worth 359.4 Million USD By 2022|Key players are Roquette Freres Le Romarin , Ingredion , Kerry Group, NOW Foods/NOW Health Group, Inc. Axiom Foods , Burcon Nutrascience Corporation, Glanbia plc., Cosucra Groupe Warcoing SA, SOTEXPRO SA
Pea Protein Market Worth 359.4 Million USD By 2022|Key players are Roquette Frer …
The Pea protein market is driven by the increasing awareness about the benefits of protein and growing demand for protein-rich diet, growing health & wellness trend, increasing consumers’ focus on meat alternatives, growing demand from food & beverage industry, various advancements in ingredient technologies such as microencapsulation, and increasing soy free and gluten free trend. In addition, increasing inclination towards a vegan diet and emerging economies such as Southeast Asia,

More Releases for RWE

Wood-Pellets Market Expected to Reach Nearly USD 9.0 Billion by 2031 | RWE Innog …
QYResearch A newly published report titled "Global Wood-Pellets Market 2025 is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Wood-Pellets market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and
U.S. Real-World Evidence (RWE) Solutions Market - Forecast to 2029
Meticulous Research®- leading U.S. market research company published a research report titled "U.S. Real-World Evidence (RWE) Solutions Market by Component [Datasets (Clinical, Claims, Pharmacy, Integrated), Services], Application (Market Access, Oncology, Neurology, Post Market Surveillance), End User (Pharma Companies, Providers)- Forecast to 2029." Download Free Research PDF @ https://www.meticulousresearch.com/download-sample-report/cp_id=5243 According to this latest publication from Meticulous Research®, the U.S. real-world evidence (RWE) solutions market is expected to grow at a CAGR of 13.1%
Real-world Evidence (RWE) Analytics Market Worth $2.93 billion by 2029
Meticulous Research®-a leading global market research company, published a research report titled, 'RWE Analytics Market by Application [Market Access & Reimbursement, Drug Development & Approval (Oncology, Neurology, Cardiovascular), Post Market Surveillance, Medical Device Development], End User (Pharma, Payer, Provider) - Global Forecast to 2029'. Access Complete Free Sample PDF Copy Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5306 According to this latest publication from Meticulous Research®, the global real-world evidence (RWE) analytics market is expected to grow
Sales of Real World Evidence/RWE Solutions Industry by 2031 | GIS
Global Real World Evidence/RWE Solutions Market report from Global Insight Services is the single authoritative source of intelligence on Real World Evidence/RWE Solutions Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data
Real-World Evidence (RWE) Oncology Market Worth $1.65 Billion by 2029
According to a new market research report titled, 'RWE Oncology Market by Component (Datasets [EHR, Claims, Cancer Registries], Consulting & Analytics Services), Application (Drug Development, Approval, Market Access, Post-market Surveillance), and End User (Pharma, Payer) - Global Forecast to 2029,' published by Meticulous Research®, the real-world evidence oncology solutions market is expected to grow at a CAGR of 14.2% from 2022-2029 to reach $1.65 billion by 2029. Download Free Sample Report
Nuclear Power Plant Market Next Big Thing | Kepco, Magnox, RWE, Entergy
Nuclear power plant (NPP) uses nuclear fission reaction to heat water to produce steam which runs the turbines to generate electricity. The fission process occurs inside the reactor where uranium fuel is stored in its core. Considering the high fuel to output ratio produced by these power plants, countries are heavily investing in development of nuclear power plant. United States accounts for 20% of their total electricity production through nuclear